What is the drop rate per minute for dobutamine (Dobutrex) in 500 ml of D5W (Dextrose 5% in Water) administered via microdrip to a 35 kg man?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dobutamine Administration Calculation for a 35 kg Patient

For a 35 kg patient, dobutamine in 500 ml of D5W administered via microdrip should be infused at 42 drops per minute when using a standard starting dose of 2.5 μg/kg/min.

Calculation Process

To determine the correct drop rate for dobutamine administration, we need to follow these steps:

  1. Determine the appropriate concentration of dobutamine
  2. Calculate the infusion rate in mL/hr
  3. Convert to drops per minute using the microdrip factor (60 drops/mL)

Step 1: Preparation of Dobutamine Solution

According to the FDA drug label, dobutamine must be diluted in an IV solution such as 5% Dextrose (D5W) 1. For this patient, we're using 500 mL of D5W as the diluent.

Step 2: Determining the Appropriate Dose

The European Society of Cardiology guidelines recommend starting dobutamine at 2.5 μg/kg/min for patients with heart failure 2. This is an appropriate starting dose that can be titrated based on clinical response.

Step 3: Calculating the Infusion Rate

For a 35 kg patient at 2.5 μg/kg/min:

  • Dose = 2.5 μg/kg/min × 35 kg = 87.5 μg/min

If we assume a standard concentration of 1000 μg/mL (1 mg/mL) in the 500 mL solution:

  • Flow rate (mL/hr) = (87.5 μg/min × 60 min/hr) ÷ 1000 μg/mL = 5.25 mL/hr

Step 4: Converting to Microdrip Rate

With a microdrip administration set (60 drops/mL):

  • Drop rate = 5.25 mL/hr × 60 drops/mL ÷ 60 min/hr = 5.25 drops/min

However, this calculation assumes a standard concentration. Let's calculate using the FDA-provided table for a more accurate result:

For a 35 kg patient at 2.5 μg/kg/min using a 500 μg/mL concentration:

  • According to the FDA table, a 30 kg patient would receive 9 mL/hr and a 40 kg patient would receive 12 mL/hr 1
  • For a 35 kg patient: 9 + (35-30)/(40-30) × (12-9) = 9 + 0.5 × 3 = 10.5 mL/hr

Converting to drops/min with microdrip (60 drops/mL):

  • 10.5 mL/hr × 60 drops/mL ÷ 60 min/hr = 10.5 drops/min

Titration Protocol

The dose should be titrated based on the patient's response:

  • Start at 2.5 μg/kg/min (10.5 mL/hr or 10.5 drops/min)
  • Double the dose every 15 minutes according to response or tolerability 2
  • For a 35 kg patient at 5 μg/kg/min: 21 drops/min
  • For a 35 kg patient at 10 μg/kg/min: 42 drops/min

Important Monitoring Parameters

During dobutamine infusion, monitor:

  1. Heart rate and rhythm
  2. Blood pressure
  3. Oxygen saturation
  4. Urine output
  5. Signs of improved tissue perfusion (skin temperature, capillary refill)

Precautions and Considerations

  • Doses >20 μg/kg/min are rarely needed and may increase risk of adverse effects 2
  • Watch for excessive tachycardia, arrhythmias, or myocardial ischemia 2
  • Dobutamine may have mild vasodilator activity due to β2-adrenergic stimulation 2
  • For patients on beta-blockers, the hemodynamic effects of dobutamine may be blunted 3
  • The patient should be kept under regular observation until stabilized 2

Alternative Approach for Higher Concentration

If using a higher concentration of 1000 μg/mL:

  • For a 35 kg patient at 2.5 μg/kg/min: 5.25 mL/hr or 5.25 drops/min
  • For a 35 kg patient at 5 μg/kg/min: 10.5 mL/hr or 10.5 drops/min
  • For a 35 kg patient at 10 μg/kg/min: 21 mL/hr or 21 drops/min

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.